Zobrazeno 1 - 10
of 84
pro vyhledávání: '"imSAVAR"'
Autor:
Neuhaus, Vanessa1 (AUTHOR), Clerbaux, Laure-Alix2 (AUTHOR), Sewald, Katherina1 (AUTHOR) Katherina.Sewald@item.fraunhofer.de
Publikováno v:
Journal of Immunotoxicology. 2024 Suppl 1, Vol. 21, pS1-S4. 4p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss sup1, Pp S1-S4 (2024)
Innovative therapeutics like biologicals that modulate the immune system are on the rise. However, their immune-modulating characteristics can also lead sometimes to the induction of adverse effects, by triggering unintended immune reactions. Due to
Externí odkaz:
https://doaj.org/article/babf2aa6d7784239a2b405337594a39d
Autor:
Armin Braun, Susann Dehmel
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss sup1, Pp S96-S98 (2024)
The chances and opportunities in modern biology inspired devising new therapeutics are mind blowing. The promises reach from successfully treating so-far incurable diseases like cancer and certain infections, to modulating and fine tuning the immune
Externí odkaz:
https://doaj.org/article/fb2bfa6d61f443f3b5d2d595519cdfde
Autor:
Braun, Armin1,2,3,4 (AUTHOR) armin.braun@item.fraunhofer.de, Dehmel, Susann1,2,3 (AUTHOR)
Publikováno v:
Journal of Immunotoxicology. 2024 Suppl 1, Vol. 21, pS96-S98. 3p.
Autor:
Patricia Gogesch, Samira Ortega Iannazzo, Tamara Zimmermann, Remi Villenave, Katherina Sewald, Zoe Waibler
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss sup1, Pp S79-S88 (2024)
Immune-related adverse outcome pathways (irAOPs) are a toxicological tool for the structuring of complex immunological mechanisms. The EU-funded IMI-project imSAVAR analyses the applicability of irAOPs in pre-clinical safety assessment of immunothera
Externí odkaz:
https://doaj.org/article/37baf8df18444b06be160907ea3e0dee
Autor:
Luise A. Roser, Charline Sommer, Samira Ortega Iannazzo, Christina Sakellariou, Zoe Waibler, Patricia Gogesch
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss sup1, Pp S38-S47 (2024)
Interleukin-2 (IL-2) was one of the first cytokines discovered and its central role in T cell function soon led to the notion that the cytokine could specifically activate immune cells to combat cancer cells. Recombinant human IL-2 (recIL-2) belonged
Externí odkaz:
https://doaj.org/article/30b72627c34e481289f3cb73c5bfb48d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charline Sommer, Vanessa Neuhaus, Patricia Gogesch, Thierry Flandre, Susann Dehmel, Katherina Sewald
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss sup1, Pp S48-S59 (2024)
The skin is the organ most often affected by adverse drug reactions. Although these cutaneous adverse drug reactions (CADRs) often are mild, they represent a major burden for patients. One of the drugs inducing CADRs is aldesleukin, a recombinant int
Externí odkaz:
https://doaj.org/article/d7da3c4f6c9e4169b6cac7a4e73a7e96
Autor:
Alb, M., Einsele, H., Loskill, P., van der Meer, A., Sewald, K., Reiche, K., Köhl, U., Hudecek, M.
Publikováno v:
In Cytotherapy May 2022 24(5) Supplement:S122-S122